Thrombocytopenia Treatment Market: By Drug Class, By Disease Indication, By Distribution Channel, and Region Forecast 2019-2030.

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Thrombocytopenia Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region Forecast 2019-2030.

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Thrombocytopenia Treatment Market size was valued at US$ 5.2 billion in 2023 and is poised to grow at a significant CAGR of 6.2% from 2024-2030. The root cause of thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. The market is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

Thrombocytopenia Treatment Market Key Developments 

In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA).

summary download arrow Download Free Sample

Thrombocytopenia Treatment Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

6.2%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Thrombocytopenia Treatment Market Dynamics

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and underdeveloped countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

Thrombocytopenia Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2023

US$ 5.2 billion

Market CAGR

6.2%

By Drug Class

  • Lysosomal Enzyme
  • Platelet Stimulating Agent
  • Glucocorticoids

By Disease Indication

  • Leukemia
  • Hemolytic Uremic Syndrome
  • Immune Thrombocytopenia
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The thrombocytopenia treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The thrombocytopenia treatment market size was valued at US$ 5.2 billion in 2023 and is poised to grow at a significant CAGR of 6.2% from 2024-2030.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players Merck & Co., Inc. (U.S), Bristol-Myers Squibb Company (U.S), ViroMed Co., Ltd (South Korea), Rigel Pharmaceuticals, Inc. (U.S), Shionogi & Co., Ltd. (Japan), Cellerant Therapeutics, Inc. (U.S)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Thrombocytopenia Treatment Market Introduction 
2.1.Global Thrombocytopenia Treatment Market  - Taxonomy
2.2.Global Thrombocytopenia Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Disease Indication
2.2.3.Distribution Channel
2.2.4.Region
3. Global Thrombocytopenia Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Thrombocytopenia Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Thrombocytopenia Treatment Market  By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Lysosomal Enzyme
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Platelet Stimulating Agent
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Glucocorticoids
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Thrombocytopenia Treatment Market  By Disease Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Leukemia
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hemolytic Uremic Syndrome
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Immune Thrombocytopenia
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Thrombocytopenia Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Thrombocytopenia Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Thrombocytopenia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Lysosomal Enzyme
9.1.2.Platelet Stimulating Agent
9.1.3.Glucocorticoids
9.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Leukemia
9.2.2.Hemolytic Uremic Syndrome
9.2.3.Immune Thrombocytopenia
9.2.4.Others
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Online Pharmacies
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Thrombocytopenia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Lysosomal Enzyme
10.1.2.Platelet Stimulating Agent
10.1.3.Glucocorticoids
10.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Leukemia
10.2.2.Hemolytic Uremic Syndrome
10.2.3.Immune Thrombocytopenia
10.2.4.Others
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Thrombocytopenia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Lysosomal Enzyme
11.1.2.Platelet Stimulating Agent
11.1.3.Glucocorticoids
11.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Leukemia
11.2.2.Hemolytic Uremic Syndrome
11.2.3.Immune Thrombocytopenia
11.2.4.Others
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Thrombocytopenia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Lysosomal Enzyme
12.1.2.Platelet Stimulating Agent
12.1.3.Glucocorticoids
12.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Leukemia
12.2.2.Hemolytic Uremic Syndrome
12.2.3.Immune Thrombocytopenia
12.2.4.Others
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Thrombocytopenia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Lysosomal Enzyme
13.1.2.Platelet Stimulating Agent
13.1.3.Glucocorticoids
13.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Leukemia
13.2.2.Hemolytic Uremic Syndrome
13.2.3.Immune Thrombocytopenia
13.2.4.Others
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck & Co., Inc. (U.S)
14.2.2.Bristol-Myers Squibb Company (U.S)
14.2.3.ViroMed Co., Ltd (South Korea)
14.2.4.Rigel Pharmaceuticals, Inc. (U.S)
14.2.5.Shionogi & Co., Ltd. (Japan)
14.2.6.Cellerant Therapeutics, Inc. (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Merck & Co., Inc. (U.S)
  • Bristol-Myers Squibb Company (U.S)
  • ViroMed Co., Ltd (South Korea)
  • Rigel Pharmaceuticals, Inc. (U.S)
  • Shionogi & Co., Ltd. (Japan)
  • Cellerant Therapeutics, Inc. (U.S)

Related Industry Reports

Immune Thrombocytopenia Treatment Market

Thrombectomy Devices Market

Global Venous Thromboembolism Devices Market

Venous Thromboembolism Treatment Market